MSH2 and cancer: This detailed variant mapping, illustrated in Figure 2 and Figure 3, provides valuable insight into the mutation landscape and its clinical impact, revealing a predominance of stop codon/frameshift variants in MSH2 gene, whereas MLH1 variants include a notable mix of intronic and large deletion variants, each contributing differently to cancer risk.